Christoph Hagemeyer

Assoc Professor

  • 99 Commercial Road, Monash AMREP building Level 1, Walkway, via The Alfred Centre

    3004 Melbourne


Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Personal profile

Monash teaching commitment

HUP3011 - Human pathology: Atherosclerosis

HUP3011 - Human pathology: Vascular biology and disease

IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy

Central Clinical School Honours program "Molecular Imaging Technology"


Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.


Education/Academic qualification

Chemistry, PhD, University of Freiburg

Chemistry, MSc, University of Freiburg

External positions

NHMRC Senior Research Fellow, National Health & Medical Research Council (NHMRC)

1 Jan 201931 Dec 2023

A/Prof, RMIT University

1 Mar 2014 → …


  • PET CT
  • acute MI
  • animal models of human disease
  • antibodies
  • arterial thrombosis
  • drug delivery systems
  • microbubbles
  • molecular imaging
  • platelets
  • thrombosis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2023

Research Output 1999 2019


Astria, E., Thonhofer, M., Ricco, R., Liang, W., Chemelli, A., Tarzia, A., Alt, K., Hagemeyer, C. E., Rattenberger, J., Schroettner, H., Wrodnigg, T., Amenitsch, H., Huang, D. M., Doonan, C. J. & Falcaro, P., 1 Jun 2019, In : Materials Horizons. 6, 5, p. 969-977 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Development of a novel peptide tracer for detection of cardiac fibrosis and atrial fibrillation using mouse models of cardiomyopathies

Niego, B., Alt, K., Noor, A., How, O. J., Du, X-J., Donnelly, P. S., McMullen, J. & Hagemeyer, C., 9 Jul 2019.

Research output: Contribution to conferenceAbstractOtherpeer-review

Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine

Hashad, R. A., Lange, J. L., Tan, N. C. W., Alt, K. & Hagemeyer, C. E., 2019, Bioconjugation : Methods in Molecular Biology. Massa, S. & Devoogdt, N. (eds.). New York, NY: Humana Press, p. 67-80 14 p. (Methods in Molecular Biology; vol. 2033).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Functional Brush Poly(2-ethyl-2-oxazine)s: Synthesis by CROP and RAFT, Thermoresponsiveness and Grafting onto Iron Oxide Nanoparticles

Klein, T., Parkin, J., de Jongh, P. A. J. M., Esser, L., Sepehrizadeh, T., Zheng, G., De Veer, M., Alt, K., Hagemeyer, C. E., Haddleton, D. M., Davis, T. P., Thelakkat, M. & Kempe, K., May 2019, In : Macromolecular Rapid Communications. 40, 10, 6 p., 1800911.

Research output: Contribution to journalArticleResearchpeer-review

Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake

Cui, J., Alt, K., Ju, Y., Gunawan, S. T., Braunger, J. A., Wang, T. Y., Dai, Y., Dai, Q., Richardson, J. J., Guo, J., Björnmalm, M., Hagemeyer, C. E. & Caruso, F., 9 Sep 2019, In : Biomacromolecules. 20, 9, p. 3592-3600 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Activities 2013 2014

  • 2 Editorial responsibility

Cardiovascular Therapeutics (Journal)

Christoph Hagemeyer (Associate editor)
2014 → …

Activity: Publication peer-review and editorial work typesEditorial responsibility

PLoS ONE (Journal)

Christoph Hagemeyer (Associate editor)
2013 → …

Activity: Publication peer-review and editorial work typesEditorial responsibility